Evidence map›Paper›PMID 30873505›Full record

ArticleBioactive materials2019

Surface bioactivation of PEEK by neutral atom beam technology.

Joseph Khoury, Irina Selezneva, Sergei Pestov, Vadim Tarassov, Artem Ermakov, Andrey Mikheev, Mikhail Lazov, Sean R Kirkpatrick, Dmitry Shashkov, Alexandre Smolkov

Open access · goldAbstract read
In one paragraph

Article in Bioactive materials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 52 citations in OpenAlex.

  1. [Research progress on enhancing osseointegration properties of polyetheretherketone implants through various modification methods].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Joseph KhouryExogenesis Corporation, Billerica, MA, USA.
Irina SeleznevaInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Moscow Region, Russia.
Sergei PestovMIREA - Russian Technological University, Moscow, Russia.
Vadim TarassovOAO Technotransservice Engineering, Moscow, Russia.
Artem ErmakovInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Moscow Region, Russia.
Andrey MikheevInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Moscow Region, Russia.
Mikhail LazovMIREA - Russian Technological University, Moscow, Russia.
Sean R KirkpatrickExogenesis Corporation, Billerica, MA, USA.
Dmitry ShashkovExogenesis Corporation, Billerica, MA, USA.
Alexandre SmolkovMIREA - Russian Technological University, Moscow, Russia.
Exogenesis (United States) · USInstitute of Theoretical and Experimental Biophysics · RUMIREA - Russian Technological University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyetheretherketone (PEEK) is an alternative to metallic implants and a material of choice in many applications, including orthopedic, spinal, trauma, and dental. While titanium (Ti) and Ti-alloys are widely used in many intraosseous implants due to its biocompatibility and ability to osseointegrate, negatives include stiffness which contributes to shear stress, radio-opacity, and Ti-sensitivity. Many surgeons prefer to use PEEK due to its biocompatibility, similar elasticity to bone, and radiolucency, however, due to its inert properties, it fails to fully integrate with bone. Accelerated Neutral Atom Beam (ANAB) technology has been successfully employed to demonstrate enhanced bioactivity of PEEK both

Identifiers

PMID30873505
PMCPMC6400009
OpenAlexW2947067326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.